{"id":266,"date":"2015-02-09T17:03:28","date_gmt":"2015-02-09T22:03:28","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=266"},"modified":"2015-02-09T17:03:28","modified_gmt":"2015-02-09T22:03:28","slug":"secondarys-announced-2-9-2015","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondarys-announced-2-9-2015\/","title":{"rendered":"Secondary’s Announced 2.9.2015"},"content":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record<\/a> for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. To subscribe to his secondary ratings, click here. <\/a><\/p>\n

Company: Idera Pharmaceuticals<\/strong>
\nSymbol: IDRA
\nPrice: Last trade $4.06
\nTrade Date: 2\/13
\nShares: 18.5 million
\nUnderwriter(s) Goldman Sachs, J.P. Morgan
\nRating=Subscription Needed<\/a><\/p>\n

Company: The Ensign Group, Inc.<\/strong>
\nSymbol: ENSG
\nPrice: Last trade $42.16
\nTrade Date: 2\/12
\nShares: 2.5 million
\nUnderwriter(s) Wells Fargo Securities
\nRating=Subscription Needed<\/a><\/p>\n

Company: RedHill Biopharma Ltd.<\/strong>
\nSymbol: RDHL
\nPrice: Last trade $14.60
\nTrade Date: 2\/10
\nShares: 690,000
\nUnderwriter(s) Wells Fargo Securities
\nCo Manager(s) MLV & Co.
\nRating=Subscription Needed<\/a><\/p>\n

Company: Atara Biotherapeutics, Inc.<\/strong>
\nSymbol: ATRA
\nPrice: Last trade $18.30
\nTrade Date: 2\/12
\nShares: 3 million
\nUnderwriter(s) Goldman Sachs, Citigroup
\nCo Manager(s) Jefferies
\nRating=Subscription Needed<\/a><\/p>\n

Company: Rose Rock Midstream, L.P.<\/strong>
\nSymbol: RRMS
\nPrice: Last trade $42.00
\nTrade Date: 2\/10
\nShares: 2 million
\nUnderwriter(s) RBC Capital Markets, Morgan Stanley, UBS Investment Bank, Wells Fargo Securities
\nRating=Subscription Needed<\/a><\/p>\n

Company: GrubHub Inc.-Block<\/strong>
\nSymbol: GRUB
\nPrice: Last trade $39.08
\nTrade Date: 2\/10
\nShares: 3.95 million
\nUnderwriter(s) Morgan Stanley
\nRating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. To subscribe to his secondary ratings, click here. Company: Idera Pharmaceuticals<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[114,113,118,116,115,117],"class_list":["post-266","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-atra","tag-ensg","tag-grub","tag-idra","tag-rdhl","tag-rrms"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/266","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=266"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/266\/revisions"}],"predecessor-version":[{"id":267,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/266\/revisions\/267"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=266"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=266"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=266"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}